Joining Fred Hutch in 2015 as vice president of business development, Dr. Robinson quickly distinguished herself, first adding strategy to her portfolio, then serving as deputy COO until her current appointment in 2022. When Fred Hutch took on a major national role in coordinating federal Covid-19 vaccine trials, she helped address the pandemic’s operational impacts and oversaw communications involving many high-profile external components. She played a pivotal role in the successful 2022 merger of Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance and helped restructure its relationship with UW Medicine, with Fred Hutch now serving as its adult cancer program.
